STAND. COM. REP. NO. 536-18
RE: H.B. No. 1924
Honorable Scott K. Saiki
Speaker, House of Representatives
Twenty-Ninth State Legislature
Regular Session of 2018
State of Hawaii
Your Committee on Health & Human Services, to which was referred H.B. No. 1924 entitled:
"A BILL FOR AN ACT RELATING TO HEALTH,"
begs leave to report as follows:
The purpose of this measure is to require franchise retail food establishments to maintain nutritional information on their standard menu items and make that information readily available to the public upon request.
After holding a public hearing on this measure, your Committee made available for public review a proposed H.D. 1 of this measure. The proposed H.D. 1 deleted the contents of this measure and inserted provisions that authorize a pharmacist to prescribe and dispense opioid antagonists without a written collaborative agreement; provided that the pharmacist meets certain qualification requirements and the individual receiving the prescription receives opioid antagonist education and signs an acknowledgment.
At the public hearing for the proposed H.D 1, your Committee received testimony from the Department of Health, Board of Pharmacy, Walgreen Co., Hawaii Immunization Coalition, and two individuals in support of the proposed H.D. 1. The Hawaii Medical Service Association provided comments on the proposed H.D. 1.
Your Committee has amended this measure by adopting the proposed H.D. 1 and by making further amendments which:
(1) Require opioid antagonists be prescribed and dispensed in the name of the individual who requests the opioid antagonist;
(2) Remove caregivers of individuals who are at risk of opioid overdose as authorized persons to whom a pharmacist may prescribe and dispense opioid antagonists;
(3) Remove the requirement that a pharmacist notify a practitioner who authorized the original opioid prescription when the pharmacist prescribes and dispenses any subsequent opioid antagonist;
(4) Remove the requirement that a pharmacy maintain the acknowledgment;
(5) Remove the preamble and appropriation for drug treatment;
(6) Change the effective date to July 1, 3000, to promote further discussion; and
(7) Make technical, nonsubstantive amendments for clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1924, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1924, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.
Respectfully submitted on behalf of the members of the Committee on Health & Human Services,
JOHN M. MIZUNO, Chair